Use of neuroendocrine serum markers in t
✍
Angelsen, Anders; Syversen, Unni; Stridsberg, Mats; Haugen, Olav A.; Mjølnerød,
📂
Article
📅
1997
🏛
John Wiley and Sons
🌐
English
⚖ 274 KB
👁 2 views
Neuroendocrine (NE) differentiation of prostatic adenocarcinomas has received increasing attention in recent years as a result of possible implications on prognosis and therapy. The incidence of NE cells in tumors has been reported from 10% up to 100%. Several studies have shown chromogranin A (CgA)